Login
$SBFM
$2.60 -$0.10 (3.7%) Live

$SBFM 8-K/A SEC Filings

Filed On Filing
12 Dec 2022 8-K/A: Financial Statements and Exhibits

Effective October 20, 2022, Sunshine Biopharma, Inc. (“Sunshine” or the “Company”) entered into a Share Purchase Agreement with Nora Pharma Inc. (the “Nora Purchase Agreement”), wherein the Company acquired all of the issued and outstand...

09 Aug 2016 8-K/A: Unregistered Sales of Equity Securities

As previously reported, on October 8, 2015, we acquired U.S. Patent Number 8,236,935 (the “Patent”) for the anticancer compound, Adva-27a, which includes all rights to this intellectual property within the United States in exchange for a...

07 Feb 2012 8-K/A: Changes in Registrant's Certifying Accountant

On January 30, 2012 my appointment as auditor for Sunshine Biopharma, Inc. ceased. I have read Sunshine Biopharma, Inc.’s statements included under Item 4.01 of its Form 8-K/A dated February 6, 2012 and agree with such statements, insofa...

19 Jan 2010 8-K/A: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities +2 more

THIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made this 20th day of August, 2009, by and between Advanomics Corporation, a Canadian corporation (the “Licensor”), with its principal place of business at 6100 Royalmount Avenue, Mon...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support